Senior insider sale
Chief Commercial Officer at PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$28.8K
9.44K shares
What this filing means
LUDWIG JEFFREY JEROME plans to sell 9.44K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $28.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/2/2025ACC: 0001610717-25-000003
Officer· Chief Commercial Officer
Since Mar 2020
9.44K
Shares to sell
$28.8K
Approx. market value
94.04K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Unit Grant
Compensation for Services Rendered
2/12/2024
27.07KRestricted Stock Unit Grant
Compensation for Services Rendered
2/10/2023
66.97KTotal acquired94.04K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/12/2024 | Restricted Stock Unit Grant Compensation for Services Rendered | 27.07K | — |
2/10/2023 | Restricted Stock Unit Grant Compensation for Services Rendered | 66.97K | — |
| Total | 94.04K | ||
Planned & Completed Dispositions1
NASDAQGSPlanned
Units to sell
9.44K
Market value
$28.8K
1/2/2025
Total
Units
9.44K
Value
$28.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/2/2025 | 9.44K | $28.8K | NASDAQGS | Planned |
| Total | 9.44K | $28.8K | ||